- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Type 1 Diabetes Mellitus With Hypoglycaemia in New Zealand
Total 1385 results
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); New...Active, not recruitingType 2 Diabetes | Pre-DiabetesUnited States
-
Avid RadiopharmaceuticalsPfizerCompletedType 2 DiabetesUnited States
-
University of VirginiaNovo Nordisk A/SRecruitingType 2 DiabetesUnited States
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada
-
PfizerTerminatedDiabetes Mellitus, Type 1Denmark, Spain, Sweden, United States, Belgium, Austria, France, Portugal, Ireland, United Kingdom, Finland, Netherlands, Norway
-
PfizerCompletedDiabetes Mellitus, Type 1United States, Canada
-
Albert Einstein College of MedicineRobert C. Atkins FoundationCompletedType 2 DiabetesUnited States
-
Bristol-Myers SquibbMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, Peru, Taiwan, Australia, Philippines, Thailand, Brazil, Chile, India, Russian Federation, Ukraine
-
PfizerCompletedDiabetic NephropathyUnited States, Spain, Korea, Republic of, Australia, Hong Kong, Germany, Poland, Italy, Canada, Puerto Rico, Malaysia, Romania, Argentina, Peru
-
University of SydneyCompletedDiabetes Mellitus, Type 2 | Insulin ResistanceAustralia
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States, Canada, Mexico, India, Puerto Rico, Russian Federation, South Africa
-
University of New MexicoNot yet recruitingType 2 Diabetes Mellitus | PreDiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus Type 2United States
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedObesity | Cardiovascular Disease | Diabetes Mellitus, Type IIUnited States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedType 2 Diabetes MellitusGermany
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusArgentina, United States, Mexico, Croatia, Austria, Romania, South Africa, Slovenia
-
Juan J BadimonAstraZenecaCompletedCoronary Artery Disease | Type-2 Diabetes MellitusUnited States
-
Tulane University School of MedicineAstraZenecaCompletedHypertension | Type 2 DiabetesUnited States
-
Profil Institut für Stoffwechselforschung GmbHHeinrich-Heine University, DuesseldorfCompletedType 2 Diabetes MellitusGermany
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Lithuania, Netherlands, Puerto Rico, Romania, Slovakia, Sweden
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type II | Diabetes Mellitus, Non Insulin DependentUnited States, Poland, Bulgaria, India, Malaysia, Romania, Canada, Russian Federation, Argentina, Puerto Rico, Czech Republic, United Kingdom, Mexico
-
NYU Langone HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingDiabetes Mellitus | Non Insulin Dependent Diabetes MellitusUnited States
-
Universität Duisburg-EssenCompletedDiabetes Mellitus, Type 2 | Diabetic NeuropathyGermany
-
Daiichi Sankyo, Inc.Completed
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2France, United States, Mexico, United Kingdom, Spain, Canada, New Zealand, Thailand, Russian Federation, Brazil, Germany, Australia, Poland, Slovakia, Peru, Ukraine, South Africa, Costa Rica, Puerto Rico
-
Ionis Pharmaceuticals, Inc.TerminatedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes | Type 2 Diabetes MellitusTaiwan, Turkey, India, Algeria, Hong Kong, China, Ukraine
-
PhaseBio Pharmaceuticals Inc.CompletedType 2 Diabetes MellitusUnited States
-
NYU Langone HealthWashington University School of MedicineTerminatedPatients Who Consented to Undergo Laparoscopic Gastric Banding Surgery for Weight Loss and Consent to Participate in This studyBMI ≥35 kg/m2 | Confirmed Type 2 Diabetes Treated With Oral Agents and/or Only Diet Therapy | Age 18-64 YearsUnited States
-
Concert PharmaceuticalsCompletedType 2 Diabetes Mellitus | Chronic Kidney DiseaseUnited States
-
SanofiCompletedType 2 Diabetes MellitusFrance, Poland, Germany, Italy, Netherlands, Belgium, Denmark, Chile, South Africa, Australia, Argentina
-
Emory UniversityNovo Nordisk A/SCompleted
-
PfizerCompletedType 2 Diabetes MellitusUnited States, Canada
-
University of New MexicoCompletedInsulin Resistance | Type 2 DiabetesUnited States
-
Garvan Institute of Medical ResearchCompleted
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Argentina
-
Akros Pharma Inc.TerminatedType II Diabetes MellitusUnited States
-
St. Luke's-Roosevelt Hospital CenterCompletedDiabetes, Gestational | Diabetes, Type 2United States
-
RWTH Aachen UniversityBayer; Heidelberg University; CTCATerminatedArterial Hypertension | Diabetes Mellitus Type 2 IRC or NIRGermany
-
Northwell HealthCompletedType 2 Diabetes Mellitus | Vitamin B12 DeficiencyUnited States
-
Winthrop University HospitalWithdrawnType 2 Diabetes | Diabetic Foot Ulcer | Diabetic NeuropathyUnited States
-
CymaBay Therapeutics, Inc.TerminatedType 2 Diabetes MellitusUnited States, India
-
University at BuffaloAmylin Pharmaceuticals, LLC.Completed
-
Skidmore CollegeActive, not recruitingType 2 Diabetes | Protein Intake | HbA1cUnited States
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 1United States, Belgium, India, Italy, Argentina, France, Germany, Mexico, Puerto Rico
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusItaly, Poland, Hungary, Mexico, Greece, Australia
-
Albert Einstein College of MedicineCompletedType 2 Diabetes Mellitus | Insulin ResistanceUnited States
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
Mannkind CorporationCompletedType 2 Diabetes MellitusUnited States, Czech Republic, Bulgaria, Germany